VF
RDY icon

Virtu Financial’s Dr. Reddy's Laboratories RDY Stock Holding History

Virtu Financial’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,380
Closed -$276K – 1962
2024
Q3 		$276K Buy
+17,380
New +$280K 0.02% 669
2023
Q2 		– Sell
-24,855
Closed -$283K – 1946
2023
Q1 		$283K Buy
+24,855
New +$268K 0.03% 571

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Virtu Financial's RDY Position: Q4 2024 in Review

Virtu Financial sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 17,380 shares — an estimated $276K sold.

Virtu Financial first reported a position in RDY in Q1 2023 and held it in 2 quarters. The position peaked at $283K in Q1 2023. 246 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • Virtu Financial reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 17,380 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $276K.
  • Virtu Financial first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 2 quarters.
  • Virtu Financial's Dr. Reddy's Laboratories position peaked at $283K in Q1 2023.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.